Nov 07 (Reuters) - Olaplex Q3 adjusted EBITDA margin 37.5%.
Q3 adjusted EBITDA USD 44.638 million vs. IBES estimate USD 43.8 million
Q3 gross profit USD 81.734 million
Q3 sales USD 119.08 million vs. IBES estimate USD 126.2 million
Q3 adjusted net income USD 28.736 million vs. IBES estimate USD 28.1 million
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.